A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure - Concepedia

Concepedia

Publication | Open Access

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

DOI Full Paper Access

201

Citations

21

References

2015

Year

Emerson C. Perin, Kenneth M. Borow, Guilherme V. Silva, Anthony N. DeMaria, Oscar C. Marroquin, Paul P. Huang, Jay H. Traverse, Henry Krum, Donna Skerrett, Yi Zheng,

Circulation Research

Abstract

Transendocardial injections of allogeneic MPCs were feasible and safe in chronic HF patients. High-dose allogeneic MPCs may provide benefits in this population.

References

	Year	Citations

Page 1